B.PharmSemester 82024-25Pharmaceutical Product DevelopmentBP813ET

Pharmaceutical Product Development (BP813ET) - AKTU Question Paper 2024-25

B.Pharm · Semester 8 · Free PDF Download

This is the official AKTU Pharmaceutical Product Development Previous Year Question Paper for B.Pharm Semester 8, academic session 2024-25. Published by Dr. A.P.J. Abdul Kalam Technical University (AKTU/UPTU), Lucknow. Free PDF download — no login required.

Course:B.Pharm

Semester:Semester 8

Session:2024-25

University:AKTU / UPTU

Rate this paper

Questions Asked in 2024-25

Pharmaceutical Product Development (BP813ET) — complete question paper · 75 marks · 3 Hours

Section AAttempt all questions in brief. 10 x 2 = 20

a
Define preformulation
b
How will you differentiate bet ween manufacturing and quality control testing
c
Name any two solubilizers comm only used in pharmaceuticals
d
State any two regulatory cons iderations for packaging materials
e
Illustrate the concept of Quality by Design (QbD)
f
Why is stability testing impor tant in product development?
g
Differentiate between directly compressible vehicles and conventional diluents
h
Evaluate the role of excipien ts in NDDS in enhancing drug delivery. i. Mention two key characteristi cs of a good semi-solid excipient j. What are non-ionic surf actants? Give one example

Section BAttempt any two parts of the following: 2 x 10 = 20

a
Write a detailed note on pack aging materials used for sterile dosage forms with relevant examples
b
Design a suitable formulation strategy for a poorly water-soluble drug
c
Evaluate the role of cyclodext rins in enhancing solubility a nd stability of APIs with examples

Section CAttempt any five parts of the following: 7 x 5 = 35

a
Classify excipients used in parenteral formulations and expl ain any one class
b
Explain the application of sur factants in formulation of emulsions and suspensions
c
Discuss the objectives of pha rmaceutical product development
d
Analyze the significance of optimization techniques in formulation development
e
List and explain key steps in manufacturing solid dosage forms
f
Evaluate the need for quality control in packaging material selection
g
Discuss the importance of emu lsifying agents in pharmaceutical suspensions

Question text is extracted from the official AKTU question paper PDF above. Hindi translations are omitted — every question is printed in English in the original paper. Last verified: 2026-08-23.

Pharmaceutical Product Development — Other Year Papers

AKTU Pharmaceutical Product Development PYQs from other sessions

Pharmaceutical Product Development2022-23 Pharmaceutical Product Development2023-24

More B.Pharm Semester 8 (2024-25) Papers

Other subjects from same semester and session

Biostatistics And Research Methodology2024-25 Pharma Marketing Management2024-25 Experimental Pharmacology2024-25 Computer Aided Drug Design2024-25 Social And Preventive Pharmacy2024-25 Cell And Molecular Biology2024-25 Dietary Supplements And Nutraceuticals2024-25

View all B.Pharm Semester 8 2024-25 papers →